UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047544
Receipt number R000054223
Scientific Title Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]
Date of disclosure of the study information 2022/04/28
Last modified on 2022/04/21 14:15:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]

Acronym

Efficacy of plant derived ingredient [n2017006]

Scientific Title

Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]

Scientific Title:Acronym

Efficacy of plant derived ingredient [n2017006]

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effects of a plant derived ingredient on glucose metabolism in healthy male adults

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood incretin concentration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Control food consumption > wash out (1 week) > test food A consumption > wash out (1 week) > test food B consumption

Interventions/Control_2

test food A consumption > wash out (1 week) > test food B consumption > wash out (1 week) > Control food consumption

Interventions/Control_3

test food B consumption > wash out (1 week) > Control food consumption > wash out (1 week) > test food A consumption

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

(1)Healthy men
(2)Adult aged from 20 y to 60 y
(3)The person who can participate on the scheduled day
(4)The person who have given written informed consent prior to the study
(5)The person who can consume test foods
(6)The person who con record habitual lifestyle and diets

Key exclusion criteria

(1) Diabetes mellitus
(2) Having history or presence of cardiovascular disease or cerebrovascular disease
(3) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases
(4) Having history of resection of gastrointestinal tract
(5) Thyroid deficiency
(6) Smoker
(7) Heavy alcohol drinker (over 30g per day)
(8) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study
(9) Severe anemia (Hb <=7g/dL)
(10) Feeling sick due to blood collection
(11) Food allergies for test meals
(12) Food allergies for test foods
(13) Cannot take all of the test food
(14) Planned to participate in other clinical study during current study
(15) Determined to be unqualified by the physician in charge or the responsible person of the study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masanobu
Middle name
Last name Hibi

Organization

Kao Corporation

Division name

Biological Science Research laboratories

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan

TEL

03-5630-7476

Email

hibi.masanobu@kao.com


Public contact

Name of contact person

1st name Aya
Middle name
Last name Yanagimoto

Organization

Kao Corporation

Division name

Biological Science Reseach Laboratories

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan

TEL

03-5630-7476

Homepage URL


Email

yanagimoto.aya@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 28 Day


Related information

URL releasing protocol

Unpublished due to the protocol including the intellectual property rights

Publication of results

Published


Result

URL related to results and publications

works in progress

Number of participants that the trial has enrolled

18

Results

A significant difference was observed in the orimary outcome.

Results date posted

2022 Year 04 Month 21 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Healthy adults

Participant flow

18 participants completed and 18 subjects were incorporated into the analyses

Adverse events

None

Outcome measures

Blood incretin

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 10 Month 17 Day

Date of IRB

2017 Year 10 Month 17 Day

Anticipated trial start date

2017 Year 10 Month 18 Day

Last follow-up date

2018 Year 02 Month 13 Day

Date of closure to data entry

2018 Year 02 Month 13 Day

Date trial data considered complete

2018 Year 02 Month 13 Day

Date analysis concluded

2019 Year 02 Month 18 Day


Other

Other related information



Management information

Registered date

2022 Year 04 Month 21 Day

Last modified on

2022 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054223